Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Reducing Bacteria That Cause Tooth Decay: Complete Statistical AnalysisIndependent statistical analysis of Reducing Bacteria That Cause Tooth Decay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062605).
- Reducing Falls With RENEW in Older Adults Who Have Fallen: Complete Statistical AnalysisIndependent statistical analysis of Reducing Falls With RENEW in Older Adults Who Have Fallen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01080196).
- Reducing HIV Risk Among Adolescents: Evaluating Project HEART: Complete Statistical AnalysisIndependent statistical analysis of Reducing HIV Risk Among Adolescents: Evaluating Project HEART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02579135).
- Reducing Metabolic Syndrome Among Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Reducing Metabolic Syndrome Among Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03719677).
- Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: Complete Statistical AnalysisIndependent statistical analysis of Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reducing Pain of Lidocaine Injection: Complete Statistical AnalysisIndependent statistical analysis of Reducing Pain of Lidocaine Injection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02288364).
- Reducing Preterm Births in Underserved Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Reducing Preterm Births in Underserved Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344616).
- Reduction in the Occurrence of Center-Involved Diabetic Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of Reduction in the Occurrence of Center-Involved Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00090519).
- Refining the Shared Decision Making Process Survey in ADHD Medication Decisions: Complete Statistical AnalysisIndependent statistical analysis of Refining the Shared Decision Making Process Survey in ADHD Medication Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Refitting Frequent Replacement Lens Wearers Into Clariti 1 Day And 1-Day Acuvue Moist Daily Disposable Spherical Lenses: Complete Statistical AnalysisIndependent statistical analysis of Refitting Frequent Replacement Lens Wearers Into Clariti 1 Day And 1-Day Acuvue Moist Daily Disposable Spherical Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: Complete Statistical AnalysisIndependent statistical analysis of Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REFLECT-2Independent statistical analysis of Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- REFLEXIONIndependent statistical analysis of Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00813709).
- ReFOCUS1Independent statistical analysis of Reducing Frailty for Older Cancer Survivors Using Supplements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04553666).
- REFRESHIndependent statistical analysis of RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01490086).
- Regadenoson Real Time Perfusion Imaging Trial-Optison: Complete Statistical AnalysisIndependent statistical analysis of Regadenoson Real Time Perfusion Imaging Trial-Optison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489176).
- REGAiN-1AIndependent statistical analysis of Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REGALEIndependent statistical analysis of T-Reg Cell Kinetics, Stem Cell Transplant, REGALE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578539).
- REGARD-PGxIndependent statistical analysis of The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REGENESIS-LEDIndependent statistical analysis of Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REGENT-1Independent statistical analysis of Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Regional Anesthesia Following Pediatric Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Regional Anesthesia Following Pediatric Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05688670).
- Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REGKINEIndependent statistical analysis of T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578461).
- Regulatory Request NIS in Korea: Complete Statistical AnalysisIndependent statistical analysis of Regulatory Request NIS in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642717).
- REHAB-HFIndependent statistical analysis of A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness: Complete Statistical AnalysisIndependent statistical analysis of Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00288886).
- Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ReITIrateIndependent statistical analysis of Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies: primary endpoint results, effect estimate with confidence interval,…
- Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers – a Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698): Complete Statistical AnalysisIndependent statistical analysis of Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01681589).
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Relative Bioavailability of Evobrutinib Tablet Batches: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Evobrutinib Tablet Batches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07214922).
- Relative Bioavailability of of Olodaterol and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of of Olodaterol and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01153711).
- Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02572609).
- Relative Bioavailability Study of Emodepside IR-tablets and Solution: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Emodepside IR-tablets and Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03383523).
- Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- Relative Bioavailability Study of Ropinirole Implants in Parkinson’s Patients on L-Dopa Switched From Oral Ropinirole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: Complete Statistical AnalysisIndependent statistical analysis of Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873987).
- Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: Complete Statistical AnalysisIndependent statistical analysis of Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELEASEIndependent statistical analysis of PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RELEASE MSS5Independent statistical analysis of Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ReletexIndependent statistical analysis of Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…